Clinical Trials List
2025-10-23 - 2029-02-15
Phase III
Not yet recruiting1
Recruiting3
ICD-10D47.4
Osteomyelofibrosis
ICD-10D68.51
Activated protein C resistance
ICD-10D68.52
Prothrombin gene mutation
ICD-10D68.59
Other primary thrombophilia
ICD-10D68.61
Antiphospholipid syndrome
ICD-10D68.62
Lupus anticoagulant syndrome
ICD-10D68.69
Other thrombophilia
ICD-10D75.81
Myelofibrosis
ICD-10D75.89
Other specified diseases of blood and blood-forming organs
ICD-10D77
Other disorders of blood and blood-forming organs in diseases classified elsewhere
ICD-10D89.2
Hypergammaglobulinemia, unspecified
ICD-10E88.09
Other disorders of plasma-protein metabolism, not elsewhere classified
ICD-9289.8
Other specified diseases of blood and blood-forming organs
-
Trial Applicant
TAIWAN PSI HEALTH DEVELOPMENT COMPANY LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- 王閔宏 無
- Yi-Chang Liu 無
- Shih-Feng Cho 無
- 許瑞峰 無
- 謝子禹 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Sin-Syue Li 無
- Ya-Ping Chen 無
- 張力常 無
- Tsai-Yun Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YAO CHI-YUAN 無
- CHENG-HONG TSAI 無
- 李思慧 無
- MING YAO 無
- 楊鎰聰 無
- Chien-Chin Lin 無
- 田豐銘 無
- Chieh-Lung Cheng 無
- Wen-Chien Chou 無
- Huai-Hsuan Huang 無
- - - 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蔡淳光 無
- Po-Shen Ko 無
- Sheng-Hsuan Chien 無
- Ting-An Lin 無
- Chia-Jen Liu 無
- Hao-Yuan Wang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14 participants
-
Global
600 participants
